Exelixis, Inc.
Edit Page
Report
Scan day: 12 February 2014 UTC
6
Virus safety - good
Description: Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.
Size: 467 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Exelixis |
| Keywords: | |
| Description: | |
| IP-address: | 204.12.68.146 |
WHOIS Info
| NS | Name Server: NS75.WORLDNIC.COM Name Server: NS76.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 11-may-1995 Expiration Date: 12-may-2017 |